2013
P3.225 HSV-2 Seroprevalence Among Current Injection Drug Users in Estonia
Uusküla A, Raag M, Abel-Ollo K, Talu A, Rüütel K, Salekesin M, Niccolai L, White T, Heimer R. P3.225 HSV-2 Seroprevalence Among Current Injection Drug Users in Estonia. Sexually Transmitted Infections 2013, 89: a218. DOI: 10.1136/sextrans-2013-051184.0682.Peer-Reviewed Original ResearchHSV-2 seroprevalenceDrug usersHSV-2 antibody testingSexual HIV transmission riskRisk behaviorsHerpes simplex virus type 2Current injection drug usersSimplex virus type 2HSV-2 seropositivityHSV-2 infectionHIV transmission riskPrevalence of HIVSexual risk reduction interventionInjection drug usersInjection risk behaviorsRisk reduction interventionsDrug use historyVirus type 2Sexual risk behaviorsHIV/AIDSRecent behavior changesHSV2 infectionSTI prevalenceActive IDUsHIV infection
1999
Attitudes and Practices of Pharmacy Managers Regarding Needle Sales to Injection Drug Users
Farley T, Niccolai L, Billeter M, Kissinger P, Grace M. Attitudes and Practices of Pharmacy Managers Regarding Needle Sales to Injection Drug Users. Journal Of The American Pharmacists Association 1999, 39: 23-26. PMID: 9990183, DOI: 10.1016/s1086-5802(16)30411-9.Peer-Reviewed Original Research